Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion type Assertion NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_head.
- NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_provenance.
- NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion evidence source_evidence_literature NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_provenance.
- NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion SIO_000772 10688044 NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_provenance.
- NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion wasDerivedFrom befree-2016 NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_provenance.
- NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_assertion wasGeneratedBy ECO_0000203 NP276006.RASUL3ogIhS0_u79vrHzNFR8-PedzqdQAtE_WnyjU-x-4130_provenance.